Navigation Links
Japan Bioinformatics Announces Release of a Case Study on Detecting SNPs and Short INDELs
Date:4/25/2013

Tokyo, Japan (PRWEB) April 25, 2013

TOKYO, Japan – April 25, 2013 – Japan Bioinformatics, today announced the release of their case study: Simbiot® ‘How To’: SNP and INDEL Detection.

The case study describes several approaches for performing the identification of mutations, including single nucleotide polymorphisms (SNPs), short insertions and deletions (INDELs), as well as other genomic variations such as intermediate and long INDELs, tandem duplications, substitutions and inversions. There is a comparison of different mutation discovery algorithms, an outline of the issues of mutation analysis specific to haploid organisms, and an overview of the process of mutation detection using RNASeq data.

The case study includes four steps for detecting SNPs and short INDELs using NGS data, with a comparison of two of the most popular tools, and a look at some of the complexities in analyzing RNASeq data.

“There is significant confusion in the market regarding how to best analyze and compare NGS data. We are in constant discussions with industry and academic professionals who are looking for solutions to this problem. Simbiot® has helped many customers overcome these data inconsistencies, and be able to offer a truly differentiated, but sound platform for those analyzing genomic data,” said Boris Umylny, President of Japan Bioinformatics.

For the complete results of the analysis of sequence data, download the white paper here

Read the full story at http://www.prweb.com/releases/2013/4/prweb10661265.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Patheon to Feature its Complex Formulation Technologies Expertise at the Upcoming CPhI – P-MEC –ICSE – BioPh – Pharmatec – Medtec Japan – Conference
2. LamdaGen Corporation Announces Japan Patent Issuance for Enzymatic Diagnostic Assays on Plasmonic Nano-Sensors
3. XBiotech Announces Incorporation Of Its Wholly Owned Subsidiary XBiotech Japan KK
4. Favorable Scenario for Japan Pharma Industry in Coming Years, New Report Says
5. Japan Bioinformatics Announces the Release of their Simbiot® Time Course Analysis ‘How-To’ Guide
6. WaferGen Bio-systems and QIAGEN KK Sign Agreement for Co-Marketing in Japan
7. Elsevier and Kanazawa University in Japan Collaborate to Map Universitys Research Performance
8. Japanese Universities Offered Access to SPIE Digital Library in Collaboration with JUSTICE
9. Japan Bioinformatics Announces Study on Leading Mapping Tools for DNA Mutation Discovery
10. Sosei Group Corporation QVA149 Phase III Study Meets Primary Endpoint in Reducing Exacerbations in COPD Patients and Filings in EU and Japan by End of Year
11. First Baby With Artificial Heart in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017 ... share data, unaudited)Three Months Ended December 31,Twelve Months Ended ... $           ... 89026%Aldurazyme Net Product Revenue 3539(10)%9498(4)%Kuvan ... Product Revenue  756025%297303(2)%Vimizim Net Product ...
(Date:2/23/2017)... , Feb. 23, 2017 /PRNewswire/ - The Fight ... for Cancer Research (OICR) are pleased to report that ... A financing, with Johnson & Johnson Innovation – JJDC, ... include venture groups HealthCap, TPG Biotechnology Partners, and Genesys ... ...
(Date:2/23/2017)... 23, 2017  In Atlanta, it seems everyone has a ... intertwine to create an expressive and dynamic community unlike any ... and contribute to it. With their newest ... seeks to carry on that tradition with a unique, ... salon is the newest of 13 nationwide locations, ...
(Date:2/23/2017)... 2017  Imanis Life Sciences announced today the ... vaccinia viruses for virotherapy research. These viruses are ... proprietary, vaccinia virus-based technology platform for research use. ... a partnership with Genelux to offer researchers, for ... use in research," said Dr. Kah Whye ...
Breaking Biology Technology:
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis ... Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen wurde ... um diese Prognose zu realisieren. ... Zu den Schwierigkeiten ... Mittel für die Biobank, die Implementierung Zeit sparender Technologien, ...
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 /PRNewswire/ ... point. Driven largely by the confluence of organizations, ... users, distaste for knowledge-based systems (password and challenge ... consumer, industrial, and government systems. The market is ... been a demarcation between consumer and enterprise uses ...
Breaking Biology News(10 mins):